Photo by nci from unsplash
Immunosuppressed, RhD‐negative oncology patients tend to have lower rates of sensitization to the D antigen when they receive transfusion with RhD‐positive blood components. Clinical factors associated with alloimmunization to the… Click to show full abstract
Immunosuppressed, RhD‐negative oncology patients tend to have lower rates of sensitization to the D antigen when they receive transfusion with RhD‐positive blood components. Clinical factors associated with alloimmunization to the D antigen in RhD‐negative oncology patients when they receive transfusion with RhD‐positive red blood cells (RBCs) have not been well defined.
Keywords:
type predicts;
predicts alloimmunization;
cancer type;
rhd;
oncology
Journal Title: Transfusion
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transfusion
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!